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tors for CTLA-4. a structural homologue of the T cell activation molecule CD28. Following subcutaneous or intravenous injection. these liver-derived cells mibrrated to T cell-dependent areas of lymph nodes and spleen of unmodified. allogeneic (BI0; H.2 h ; I-E-) recipients. where they were identified 1-5 days. and i and 2 months after injection by their strong sunaet· expression of donor MHC class II <I_Ek) and their den dritic morphology. Maximal numbers of liver-derivl'( DC in the spleen were recorded 5 days after injection. Both clusters of strongly donor MHC class 11+ eellsand (more rarely' dividing cells-could also be identi· fied. suggestinl( cell replication in situ. Using the same techniques employed to generate DC prol(enitors from normal liver. GM-CSF-stimulated cells were propagated for 10 days from the bone marrow and spleen of non immunosuppressed mice sacrificed 14 days after orthotopic liver transplantation (BI0;H·2 b -C3H;H-21<,. Immunocytochemical staininl( for recipient and donor MHC cla .. II phenotype revealed the growth both of host cells with DC characteristics. and of cells expressing donor alloantigens I I-A b). These results are consistent with the growth. in response to GM-CSF. of donor-derived DC from progenitors seeded from the liver allograft to recipient lymphoid tissue. The functional activity of the progenitors of chimeric DC and the possible role of these cells in the establishment and maintenance of donor-specific tolerance following liver transplantation remain to be determined.
It is now thought that the comparative ease of~acceptance" of different transplanted organs may reflect their endowment with "passenger" leukocytes (1. 21. Of these. bone marrowderived dendritic cells mC)* are thought to be the most important. because of their capacity both to present antigens and to deliver activation signals to T cells (3--5). The liver. which is the most tolerogenic whole organ (2, (6) (7) (8) (9) (10) . has a comparatively heavy content of DC (11) (12) (13) (14) (15) , and can be transplanted across major histocompatibility barriers in most mouse strain combinations. without immunosuppression (21. Further insight into the tolerogemcity of the liver may emerge from studies of the functIOnal properties of liver DC \\ Illch, to date, have been the subject of very few tnvestigatlOns.
Recently, we have shown that DC with potent allostimulatory activity for naive T cells can be isolated from nonnal mouse liver (16 ( 17) . usmg a modification of the method of Inaba et al. (20) . The cells were harvested routinely for study after 7-10 days of culture. In some expenments. GM-CSF·stlmulated liver·denved populations were depleted of all la-rich cells by complement-dependent lvsls. usmg mouse anti-I-E k monoclonal antibody I rnAb) (PharMingen. ::ian Diego, CAl and low-toXIcity rabbit complement (Accurate Chemical & Scientific. Westbury. NY). la' cell depletIOn was confirmed by both flow cytometry and immunocytochemistry.
Flow c.vtometrlc analysis. Immunophenotyplc analysis of liver or spleen·derived cells was performed by either direct or mdirect immunotluorescence stainmg as described elsewhere. uSing an exten· sive panel of rnAbs !l71. These included antibodies directed against mouse lymphOid. myeloid and DC-restncted markers 13301. TIB227; ATCC. NLOC-145: and COllc. N41S; kmdly prOVided by Or. R.M. Steinman. Rockefeller University, New York. NY). In addition. counter-receptors of CTLA-4 (a structural homolo!tIJe of C02S1 (CTLA·.tCRl. which include CDSO family members 187IBBll and B701B7-:l. were Identified using the CTLA-.tlg fusion protein (kindly prOVided by Dr. I'.S. Lmsley, Bristol Mvers SqUibb Pharmaceutical Rl'search Institute. Seattle. WAI (211. with human 19 "Sigma) as a n"~atlve control. Flow cvtometric analYSIS was performed usmg a F \( 'STAH flow cytometer I Becton Dickmson. ::ian Jose. CAl. and five t IlI,usand t'vpnts wpre acquired for each sample.
.\flxed /cuiwcvl" culture ... To test the Immunogemcltv of cultured liver or splepn·denVl'd cells. one-way mixed leukocvte cultures were pertc)rmed 1!1 Y6-wp11. round·bottomed microculture plates With van· able numbers of GM·CSF·stlmulated. 'Y'lrradlated \:l0 Gv I allo~enelc I B 10.BHI or svngenelc I B 101 liver or spleen cells as stimulators. B10 :ipleen n~lls 14( 10'-' per well) ennched for T cells by pa.:lsa~e (1 hr, through a nvlon wool column were used as responders. Cultures were mamtal!1l'd for 72 hr: I'HITdR wall added III hr belore harvesting and the extent of DNA syntheSIS determmed bv liqUid scmtlilation counting.
ncntintlc <"iI h"mlnl!. :-.Iondepleted or la·depleted cultured l! 10.IlH livl'r· or spleen·denved cells were washed 10 Hanks' hal· ,need salt ,;olUtlon and mlected s.c. < lor 2.5" 10" cells 10 flO ",II into fle hmd ti,otpad or LV ,10" in <!OO /.Lli vIa the lateral tnt I vl'm of "rmLlI B 10 mice. Une dav to :.! months later. groups of J ammnls were killed and the draining popliteal lymph node (where appropnate'. thymus. and spleen were removed. embedded in Tissue-Tek IO.C.T. Compound. Miles. Elkhart. IN) and frozen at -70°C. Cryostat sections (5 /Lml were air-dried at room temperature (RTl overnight. then stored at -70°C until used.
Immunocytochemistry. Cryostat sections <equilibrated at RT) or cytocentnfuge preparations of cultured cells were fixed in acetone. then stained for donor MHC class II using biotinylated mouse IgG2. anti-mouse I_Ek.d.p.r or anti I_Ab mAbs <PharMingenl as appropriate. in an avidin-biotin-peroxidase complex (ABC) staining procedure. Controls included sections or cytospin preparations of normal donor or recipient strain tissues or cells. The incidence of donor MHC class II· cells in sections was determined by the mean number of positive cells per 100 high power fields (hpO.
Liver transplantatLOn. Orthotopic liver transplantation (OLTx) was performed in a mouse strain combination (BI0 to C3H; MHC class 1. II and mHC disparities) with a high acceptance rate, using techniques described previously in detail (22), wah minor modifications. No immunosuppressive therapy was used. The animals were killed 14 days after OLTx (three animals per group I.
RESULTS

Growth and immunophenotype of liver DC progenitors.
Approximately 2.5 X 10° low-density nonadherent cells with typical dendritic shape and other morphological features of DC ( Fig. 1) could be harvested per liver after 7-10 days of culture in GM-CSF. Flow cytometric analysis (summarized in Table 1 ) con finned that these cells expressed surface antigens associated with mouse DC, including CD45 (leukocytecommon antigen), heat-stable antigen, CD54 (lCAM-ll, CDllb (MAC-n and CD44 (nonpolymorphic detenninant of Pgp.l glycoprotein). In addition, staining of weak-to-moderate intensity was observed for the DC-restrIcted markers NLDC-145 (interdigitating cells). 33D1 and N418 and for F4/80 and CD32 lFcyRIIl. The Intensity of expression of these markers on GM-CSF-stimulated spleen cells was similar, except that CD32 and CDllb were reduced and :l3D1 and NLDC 145 were slightly more and less intense. respectively, compared with the liver-derIved cells. In contrast to the spleen cell progeny. which were MHC class 
inducers of pnmary allogeneic T cell responses (data not shown).
In vivo mIgration of liver-derived developing DC. We wlshed to determine the migratory ability of the liver-derived DC progenitors after their local (s.c.! or i.v. injection (in the latter instance to mimic possible consequences of liver transplantatIOn!. As shown In Figure 3 . at least some of the Iiverderived cells homed after footpad or I. v. injection almost exclusively to the T cell areas of recipients' spleens. where they were Identified by expressIOn of donor MHC class II II_Ek) in close proximity to artenoles. Similar observations were made In the draining popliteal lymph nodes of footpadInjected mIce: occaSIOnal I-E' cells were also observed in the thvmlc medulla. Manv of these chimenc cells exhibited dis-I I~ct dendntlc morphology. Donor l\IHC dass II· (I_Ek +) cells were tirst observed in Ivmph node or spleen :.!4 hr after inJectIOn. Interestingly, structures resembling weakly donor :\IHC dass II -cells were also observed in lymph nodes at 24 hr ( Fig. 3 L \\Thether these were maturing donor-derived cells IIr reCIpIent cells that had taken up shed donor MHC class II pep tides was not determined. In the spleen. maximal numbers of I_E k ' cells were found on dav 5 (Fig. 4) . Thereafter, numbers declined, but I-EK -cells were still detected in T cell :lreas :.! months after the injection of liver-derived DC progenitors. In addition to Isolated cells. aJ.,(gregates (Fig. 3e) (H-2 k . . 1, respectively. Ten days after the initiation of GM-CSF-stimulated cultures, in which selective enrichment for cells with DC characteristics was performed, a minor population of donor MHC class II+ cells could readilv he identified both in the bone marrow and spleen cell popula. tions (Fig. 5 ). Cells were also propagated for 10 days from the spleens of normal BI0 (donor strain) and C3H (recipient strain) animals and stained both for I_Ab and I_Ek, Wlth appropriate Ig isotype controls. No mAb crossreactivity was observed. These findings are therefore consistent with the ex vivo propagation of donor liver-derived DC from progenitor,;, or even stem celis, seeded in the lymphoid tissue of the orga:l allograft recipients.
DISCUSSION
Unlike GM-CSF-stimulated DC propagated from normal mouse blood (201, bone marrow (25) , or spleen, the majority of GM-CSF-stimulated cells with DC characteristics derived from liver NPC express little or no cell surface MHC class II antigen. Furthermore, as we have shown here, the liver· derived DC progenitors fail to stImulate unprimed alloreactive T cells-i n contrast to freshly isolated spleen cells Of hepatic NPC. a finding in keeping with the very low intenSity ofMHC class II and CTLA-4CR detected on their surface. A~ shown preVIOusly (171, these cells also exhibit aVld phago· cytic activity-a property of immature DC. They can h011 ever. be induced to mature in vItro (confirmmg their [) lineage) by exposure for several days to the extracelluL matnx protein type-l collagen 1/7) that is spaclallv assocI ated WIth MHC class II' DC in the portal triads Within normal liver. Recently, there has been increased speculation that such "immature" DC or DC progemtors present in nonlymphoid organs may constitute tolerogenic progemtors ot chimenc cells in recipients of organ allografts U, 17.231. A speCialized property of bone marrow-derived DC is their capacity to migrate in vivo to T-dependent areas of peripheral lymphoid tissues (18, 19) wherem they present antigen to T cells. In this study. we assessed the hommg ability ot CM-CSF-stlmulated. developing, liver-derived DC (Jow I-E" l'xpreSSlOn or la followmg complement-mediated IVSISI that were Injected eIther locallv or systemIcally (to mimiC posslbl( ~equelae of liver transplantatIOn I Into allogeneIc B 10 !I-E reCipients. \\Then the reCipients were killed after 1 to 5 da\',-at least some of the mJected cells were found to have mi' h'Tated to T cell areas of the drnlmng lymph node latter locai injection I and spleen. In these sites. they were easIly identIlied as donor by their strong cell surface staining for MHC dass II <I_EKl. Sigmticantly, the lIver-derived cells or theIr progeny perSIsted in the spleen much longer (for at least :.! months I than those donor-denved DC descnbed in the same llssue up to only 4 days after cardiac transplantation In unmodified mIce that rejected their grafts within 8-12 davs 1181. This may. of course. retlect both qualitative and quan- tl! ative difTerences In the migratory DC populatIons denved fr.ltn Itv!'r and heart. Either wav. the persistence of injected clllmerll: (!'Ils of DC lineage within lvmphoid tissue of unmodified allog'enelc reCIpIents IS consIstent wllh the failure of these arumals to reJect liver aliOI-.'Talts Ill. It is also III <lh'Teement With the survIval of donor-derived leukocvtes.lncluding DC. WIthin the central lymphOId tissue of unmodified murine liver allol-,rraft reCIpients for up to one year posttransplant (2l. Donor chimeriC leukocvtes have slmliarly been observed in spleens of liver-allografted rats up to ;JOO days posttransplant (:2/1. The comparatlvelv long survival and apparent maturation of liver DC prog'emtors homing to T cell-dependent areas of allogene\<: Ivmphold tissue IS consIstent With the contentIOn I:.'. :2·11 that the destination of donor-derIved leukocvtes. ml-,~·':ltmg alter whole organ transplantation. IS lineage-specltic. : dowlI1l.!' routes ';lImlar to those taken bv ~vngenelc cells of tile same It neages. After transplantation of the h vcr or other Ilrgans. Immature cells of DC linea!!e mav underl.!'o 1!1 VIVO ditTerentlatiorvmaturatlon 1 as shown here In terms of the llpre~'UlatlOn of cell surface MHC class II expressIOn I under the rl'~'Ulatorv tnt1uence of endogenous t;~I-CSF :lnd other cytoklnes. such as tumor necrosIs factor-" and IL--t. 111 an In VIVO recapitulation of the results of in vitro maturation 125-2il. The kinetics of this maturation process are likely to be intluenced by the extent of host ImmunosuppreSSIOn. ;,11-thou~h the general pat.hwavs of donor cell mIgration and differentiation have been shown to be much the same In liver-aliografted rats treated WIth FK506 f2.Jl. The implicat ions of the r:lpid eh'Tess from the liver 1 a potential hematolymphoid org-an 1281l of progenitor DC With replicative capacity. exhibiting low ceil surface MHC class II expressIOn and low T cell-stimulating actiVIty. are conSiderable. The implications of these findings are underscored both by the I!'ngthy persistence of these cells in nOlllmmunosuppressed hosts and by our capacity to propagate cl'lls of donor phenotvpe In vitro from the l.vmphoid tissue of liver allograft reCIpients. This latter ohservation is consistent with the detectam of presumptive proliferating 1 1O-15 r ; I donor cells within t he spleens of liver-ailogratted rats seVl'ral davs posttransplant 1:!.Jl. Taken together. these tinding:; sUl.!'gest a mecharl\:;tic basis for cytokine-driven perpetuation of donor leukocvte chimerism in recIpients of liver and other organ grafts. Thev also prOVIde support filr the therapeutic strategy of :IUh'1Tlentatlon of natural chimerism In human allograft reCIpients currentlv heing evaluated at thi:; medical center t.:!91.
The 11 . Althoul{h the precise oaSIs of DC-T cell interactions that might lead to tolerance induction is uncertain. it is most likely to depend on the relative affinity or avidity I compared \\;th "i mmunizing" antigen-presenting cells [APC] ) of donor DC-T cell receptor interactions and on the expressIOn on the former cells of critical adhesins and costimulatory molecules. such as members of the CD80 <B7-11B7-2l family. These aspects of developing liver and bone marrow-derived DC both in vitro and in vivo are under further investigation in our laboratory.
Following local or systemic injection into nonimmunosuppressed allogeneic recipients. liver-derived DC progenitors propagated in vitro homed to T-dependent areas of lymph nodes and spleen. They were detected by the expression of donor MHC class II antigen and they persisted for at least 2 months in the spleen. where rare dividing cells identified as donor were also detected. Using the same techniques employed to propagate DC progenitors from normal liver, both bone marrow and spleen cells obtained from liver allograft recipients 14 days after transplantation were cultured for 10 days in GM·CSF. This resulted in the propagation of recipient-derived cells and of cells expressing donor MHC class II antigens. suggesting the growth of donor cells from precurors seeded to host lymphoid tissue. These findings provide insight into the establishment and perpetuation of donor IAPC) cell chimerism following transplantation of the liver and possibly other organs.
• The efficacy of CTLA41g in blocking immune activation and allograft rejection (AR) was tested in an aggressive and rapid model of rat lung AR (Brown Norway [BNI -Lewis (LEWl). CTLA41g is a recombinant soluble protein that binds with high affinity to rat B7IBBl and other surface molecules on APCs. subsequently blocking the binding of B7IBBI to CD28/ CTLA4 on T cells. This interrupts the costimulatory pathway critical for complete T cell activation and ('ompletion of the AR process. Left single-lung transplants were performed between BN-Lew. Five allograft recipients were examined in each group. At transplantation, animals received 250 p.g of CTLA41g or 250 p.g of control Ig intraperitoneally daily until sacrifice. Animals were sacrificed on days 2. 4. and 7 after transplant. Control (BN-Lew~ grafts show irreversible rejection by day 7. Syngeneic (Lew-Lew~ grafts show no AR on day 7. AR episodes were graded histologically (stages O-IV) and pathologic intensity of inflammation was graded on percentage of involvement. Cytokine transcript levels were measured in control and CTLA4Ig-treated animals (n = 5 in each group I on day 7 using reverse transcriptase polymerase chain reaction techniques. The most profound .Iifferences were found on day 7 after transplant. The
